Amy Lynn Ronneberg

Amy Lynn Ronneberg

DirectoratDianthus Therapeutics, Inc. /DE/· In the 2023 proxy

Amy Lynn Ronneberg is Director of Dianthus Therapeutics, Inc. /DE/.

Experience

  1. Dianthus Therapeutics, Inc. /DE/Public company · 3 yr
    • Director2023 – Present · 3 yrStock in role +1,290%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?